tiprankstipranks
Trending News
More News >
Akari Therapeutics (AKTX)
NASDAQ:AKTX

Compare Akari Therapeutics (AKTX) vs. Competitors

Compare
340 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Akari Therapeutics
$0.28
$9.15M
-76.67%
3 Buy
0 Hold
0 Sell
Strong Buy
NanoViricides
$1.13
$25.45M
-2.32
-1.67%
1 Buy
0 Hold
0 Sell
Moderate Buy
Moleculin Biotech
$4.16
$12.81M
-0.07
-90.44%
3 Buy
0 Hold
0 Sell
Strong Buy
Passage Bio
$12.87
$40.16M
-0.89
7.25%
4 Buy
0 Hold
0 Sell
Strong Buy
SAB Biotherapeutics
$3.98
$189.48M
-1.29
11.80%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKTX
Akari Therapeutics
0.28
-1.01
-78.29%
SONN
NNVC
NanoViricides
1.18
0.06
5.36%
MBRX
Moleculin Biotech
4.16
-42.84
-91.15%
PASG
Passage Bio
12.87
0.53
4.29%
SABS
SAB Biotherapeutics
3.98
0.31
8.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts